Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer

198674 citationsJournal Article

Authors

Good health and well-being

Published in: International Journal of Radiation Oncology*Biology*Physics

Volume 12, Issue 4, pp. 587-591

Field-Weighted Citation Impact: 2.47